Are localized prostate cancer biomarkers useful in the clinical practice?
Carneiro, Arie; Priante Kayano, Paulo; Gomes Barbosa, Álan Roger; Langer Wroclawski, Marcelo; Ko Chen, Carolina; Cavlini, Giulio Costa; Reche, Guilherme Jose; Sanchez-Salas, Rafael; Tobias-Machado, Marcos; Sowalsky, Adam G; Bianco, Bianca.
; 40(9): 1010428318799255, 2018 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-30204063
A gain-of-function mutation in DHT synthesis in castration-resistant prostate cancer.
The Molecular Taxonomy of Primary Prostate Cancer.
Targeting prostate cancer: Prostate-specific membrane antigen based diagnosis and therapy.
[Biomarkers of prostate cancer and potential for using ace produced in prostate gland for diagnosis of prostate cancer and benign prostatic hyperplasia].
Current Progress and Controversies in Prostate Cancer Management.
[Prediction of life expectancy for prostate cancer patients based on the kinetic theory of aging of living systems].
Improving the Specificity of PSA Screening with Serum and Urine Markers.
Prostate-specific Antigen Density Variation Rate as a Potential Guideline Parameter for Second Prostate Cancer Detection Biopsy.
A Rich Array of Prostate Cancer Molecular Biomarkers: Opportunities and Challenges.
Spectrophotometric photodynamic diagnosis of prostate cancer cells excreted in voided urine using 5-aminolevulinic acid.